BOTULINUM TOXIN TYPE A Pharmacologic Class Indexing
- Class set ID
- f752a52c-092d-49fe-8744-de6776933ea2
- Version
- 4
- Effective date
- 20230526
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
Label, Manufacturer, Effective table| Label | Manufacturer | Effective | SPL version |
|---|
| These highlights do not include all the information needed to use XEOMIN ® safely and effectively. See full prescribing information for XEOMIN. XEOMIN (incobotulinumtoxinA) for injection, for intramuscular or intraglandular use Initial U.S. Approval: 2010 | Merz Pharmaceuticals, LLC | 20260325 | 32 |
| These highlights do not include all the information needed to use XEOMIN ® safely and effectively. See full prescribing information for XEOMIN. XEOMIN (incobotulinumtoxinA) for injection, for intramuscular or intraglandular use Initial U.S. Approval: 2010 | Merz North America, Inc. | 20260304 | 26 |
| These highlights do not include all the information needed to use BOTOX ® safely and effectively. See full prescribing information for BOTOX. BOTOX ® (onabotulinumtoxinA) for injection, for intramuscular, intradetrusor, or intradermal use Initial U.S. Approval: 1989 | Sportpharm LLC | 20260202 | 1 |
| These highlights do not include all the information needed to use DAXXIFY safely and effectively. See full prescribing information for DAXXIFY. DAXXIFY ® (daxibotulinumtoxinA-lanm) for injection, for intramuscular use Initial U.S. Approval: 2022 | Revance Therapeutics, Inc. | PCI San Diego, Inc. | A+ Secure Packaging, LLC | 20260107 | 12 |
| These highlights do not include all the information needed to use DYSPORT safely and effectively. See full prescribing information for DYSPORT. DYSPORT ® (abobotulinumtoxinA) for injection, for intramuscular use Initial U.S. Approval: April 2009 | Galderma Laboratories, L.P. | IPSEN BIOPHARM LTD | 20241024 | 12 |
| These highlights do not include all the information needed to use BOTOX Cosmetic safely and effectively. See full prescribing information for BOTOX Cosmetic. BOTOX ® Cosmetic (onabotulinumtoxinA) for injection, for intramuscular use Initial U.S. Approval: 1989 | Allergan, Inc. | 20241018 | 54 |
| These highlights do not include all the information needed to use BOTOX ® safely and effectively. See full prescribing information for BOTOX. BOTOX ® (onabotulinumtoxinA) for injection, for intramuscular, intradetrusor, or intradermal use Initial U.S. Approval: 1989 | Allergan, Inc. | 20231118 | 61 |
| These highlights do not include all the information needed to use DYSPORT safely and effectively. See full prescribing information for DYSPORT. DYSPORT ® (abobotulinumtoxinA) for injection, for intramuscular use Initial U.S. Approval: 2009 | Ipsen Biopharmaceuticals, Inc. | IPSEN BIOPHARM LTD | 20230928 | 25 |
| These highlights do not include all the information needed to use JEUVEAU ® safely and effectively. See full prescribing information for JEUVEAU . JEUVEAU (prabotulinumtoxinA-xvfs) for injection, for intramuscular use Initial U.S. Approval: 2019 | Evolus, Inc. | 20230428 | 8 |